about
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessmentActivation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.Autoimmune Hemolysis: A Journey through TimeRegulation of B-1 cell activation and its autoantibody production by Lyn kinase-regulated signallingsHumanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice.B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.Breakage of B cell tolerance and autoantibody production in anti-erythrocyte transgenic mice.Apotosis of mature B cells.From T to B and back again: positive feedback in systemic autoimmune disease.Receptor revision and systemic lupus.Role of antibody and T cells in the long-term inhibition of IgE synthesis.The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.Positive selection of natural poly-reactive B cells in the periphery occurs independent of heavy chain allelic inclusionThe Lbw2 locus promotes autoimmune hemolytic anemia.Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell developmentRegulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in MouseIgkappa allelic inclusion is a consequence of receptor editing.Increasing the chemical potential of the germ-line antibody repertoireReceptor editing: an approach by autoreactive B cells to escape tolerance.lambda 5, but not mu, is required for B cell maturation in a unique gamma 2b transgenic mouse line.Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model.The cytoplasmic domains of immunoglobulin (Ig) alpha and Ig beta can independently induce the precursor B cell transition and allelic exclusionThe fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune diseaseMigration and differentiation of autoreactive B-1 cells induced by activated gamma/delta T cells in antierythrocyte immunoglobulin transgenic mice.Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.The cellular location of self-antigen determines the positive and negative selection of autoreactive B cellsHigh pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia.Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice.Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determinationSelf-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells.Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.Virus-induced maturation and activation of autoreactive memory B cells.Use of mouse models to study the mechanisms and consequences of RBC clearance.Maintenance of tolerance by regulation of anti-myeloperoxidase B cells.Chromosomal position of rearranging gene segments influences allelic exclusion in transgenic mice.B cell clonal elimination induced by membrane-bound self-antigen may require repeated antigen encounter or cell competition
P2860
Q24675466-B314BF55-72EE-4002-9F6E-48E0ADFCC023Q24794791-9E1E3253-FEBF-4623-B112-20D1623AB867Q26773184-40EA2BE8-89A3-477A-A845-FC3859863F8FQ28509762-7C91317D-2B34-4B12-97E5-DEDC10CD09EAQ30234773-9AD4E712-5896-45A3-BF2C-B17C3618B067Q30537231-2FB921F4-7691-4CF0-9495-08A2EBDA926BQ33737706-20EC874F-94FD-421C-A439-F8FC754841B1Q33805873-F7BEB8FB-ECAC-45B2-9B7B-AB9CD09D1342Q33811739-2F42C05F-F012-47A6-A922-AA4F2E4C54E9Q34572168-BED1AB03-63E1-438A-8BDE-2759591A1642Q34613910-D2DD664C-F301-4038-BB3E-796AD81CD542Q34987422-684348F2-4104-4B45-8A91-E50063066D62Q35490321-2D1BDED1-E5C5-469C-AACF-6EBBD143FA37Q35636916-94B69AAD-C29F-4C32-AE4A-571A8427320DQ35850873-42C74B9A-5ECB-4545-81A9-85BC183A41D3Q35959398-61608E59-0303-4EDB-859B-024BAD00750AQ36041356-BD9D5985-CE8E-41B5-BE87-F2C932D2C181Q36041818-77F10962-E5FF-44AD-982B-3A94605E58A1Q36199828-7538F202-4A6E-4BF2-BE7C-FA1F69004F3AQ36228958-79F4FB23-3CA9-4A2F-AD22-AB17BD963385Q36276250-9A5FFF12-FC8B-4409-96B4-CBECEAED3457Q36361497-7706FB9D-AB72-4EC3-B16F-6538FD69576DQ36364512-B9EF3086-B168-46C5-AD4C-179ADE9DB968Q36364838-146D1B0A-712B-4266-8B37-0EAF36757D25Q36365409-F707DCC5-A69F-46AE-BD95-ED4D976E4422Q36366646-586007ED-9BA0-4D69-B72B-06D9583A1493Q36367445-A26C8693-FCF1-48EB-9409-28803BB6A6FEQ36368313-D8A84465-57D4-453A-991B-5B6AFB061DC2Q36368392-9261A418-1795-4DB3-8791-EAC0438E6747Q36371832-30C67020-488A-467B-BDB1-001F646F6B6CQ36375688-951DD84A-6191-46E1-B096-991A5C975399Q36376808-38CD8A9D-9AB8-4079-9E1E-28C96B719FA8Q36377073-FBE136F3-8213-420D-B4FF-0E63C9C555ABQ36381002-387F5F03-D319-4F9C-8C3D-8C03F20669E7Q36400683-12015963-C08E-406B-9AAC-AA47039C231CQ36404575-BDD33AA3-A79A-4A24-8C9F-4558E602342FQ36632113-42105961-5CEE-4110-98C1-67B122720469Q36842455-F34D8D0F-00BB-4727-875E-E35153117568Q36888000-EF7CEAEA-3711-49DD-A4D5-4CDD4594DB0BQ37183454-53BCEAE1-47DC-4F7E-8F46-C356219B47FD
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
A transgenic model of autoimmune hemolytic anemia.
@ast
A transgenic model of autoimmune hemolytic anemia.
@en
type
label
A transgenic model of autoimmune hemolytic anemia.
@ast
A transgenic model of autoimmune hemolytic anemia.
@en
prefLabel
A transgenic model of autoimmune hemolytic anemia.
@ast
A transgenic model of autoimmune hemolytic anemia.
@en
P2093
P2860
P356
P1476
A transgenic model of autoimmune hemolytic anemia.
@en
P2093
Murakami M
P2860
P356
10.1084/JEM.175.1.71
P407
P577
1992-01-01T00:00:00Z